# A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

> **NCT02734524** · PHASE2 · UNKNOWN · sponsor: **Southwest Hospital, China** · enrollment: 104 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** NK cells
- **DRUG:** Taxol
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02734524
- **Lead sponsor:** Southwest Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2018-03
- **Final completion:** 2019-03
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02734524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02734524, "A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02734524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*